{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:17:54Z","timestamp":1788016674863,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11916-026-01536-x","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:26:06Z","timestamp":1787970366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Headache Attributed to Genetic Vasculopathies"],"prefix":"10.1007","volume":"30","author":[{"given":"Lauren E.","family":"Yap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"1536_CR1","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1172\/JCI8047","volume":"105","author":"A Joutel","year":"2000","unstructured":"Joutel A, Andreux F, Gaulis S, Domenga V, Cecillon M, Battail N, et al. The ectodomain of the NOTCH3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest. 2000;105:597\u2013605.","journal-title":"J Clin Invest"},{"key":"1536_CR2","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1212\/WNL.0b013e31824d586c","volume":"78","author":"SK Narayan","year":"2012","unstructured":"Narayan SK, Gorman G, Kalaria RN, Ford GA, Chinnery PF. The minimum prevalence of CADASIL in northeast England. Neurology. 2012;78:1025\u20137.","journal-title":"Neurology"},{"key":"1536_CR3","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1161\/STROKEAHA.119.028840","volume":"51","author":"N Grami","year":"2020","unstructured":"Grami N, Chong M, Lali R, Mohammadi-Shemirani P, Henshall DE, Rannikm\u00e4e K, et al. Global assessment of mendelian stroke genetic prevalence in 101 635 individuals from 7 ethnic groups. Stroke. 2020;51:1290\u20133.","journal-title":"Stroke"},{"key":"1536_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/ene.15180","volume":"29","author":"GP Paraskevas","year":"2021","unstructured":"Paraskevas GP, Stefanou MI, Constantinides VC, Bakola E, Chondrogianni M, Giannopoulos S, et al. Cadasil in Greece: Mutational Spectrum and clinical characteristics based on a systematic review and pooled analysis of published cases. Eur J Neurol. 2021;29:810\u20139.","journal-title":"Eur J Neurol"},{"key":"1536_CR5","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/acn3.344","volume":"3","author":"JW Rutten","year":"2016","unstructured":"Rutten JW, Dauwerse HG, Gravesteijn G, van Belzen MJ, van der Grond J, Polke JM, et al. Archetypal NOTCH3 mutations frequent in public exome: implications for CADASIL. Ann Clin Transl Neurol. 2016;3:844\u201353.","journal-title":"Ann Clin Transl Neurol"},{"key":"1536_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jamaneurol.2024.4487","volume":"82","author":"G Gravesteijn","year":"2025","unstructured":"Gravesteijn G, Rutten JW, Cerfontaine MN, Hack RJ, Liao Y-C, Jolly AA, et al. Disease severity staging system for NOTCH3-associated small vessel disease, including CADASIL. JAMA Neurol. 2025;82:49\u201360.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1536_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3988\/jcn.2023.19.1.12","volume":"19","author":"Y Yamamoto","year":"2023","unstructured":"Yamamoto Y, Liao Y-C, Lee Y-C, Ihara M, Choi JC. Update on the epidemiology, pathogenesis, and biomarkers of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Clin Neurol. 2023;19(1):12\u201327.","journal-title":"J Clin Neurol"},{"key":"1536_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s10194-025-01980-x","volume":"26","author":"H Chabriat","year":"2025","unstructured":"Chabriat H. Is migraine a common manifestation of CADASIL? arguments pros. J Headache Pain. 2025;26:64.","journal-title":"J Headache Pain"},{"issue":"11","key":"1536_CR9","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1177\/0333102415620909","volume":"36","author":"S Guey","year":"2016","unstructured":"Guey S, Mawet J, Herv\u00e9 D, Duering M, Godin O, Jouvent E, et al. Prevalence and characteristics of migraine in Cadasil. Cephalalgia. 2016;36(11):1038\u201347.","journal-title":"Cephalalgia"},{"issue":"10","key":"1536_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/03331024251389241","volume":"45","author":"D Mascarella","year":"2025","unstructured":"Mascarella D, Zhuang ZA, Gliga O, Santis FD, Rosignoli C, Dapkute A, et al. Migraine in monogenic disorders: Shedding light on new therapeutic targets. Cephalalgia. 2025;45(10):1\u201345.","journal-title":"Cephalalgia"},{"key":"1536_CR11","unstructured":"6.8 Headache attributed to genetic vasculopathy [Internet]. ICHD-3. 2021 [cited 2026 May 30]. Available from: https:\/\/ichd-3.org\/6-headache-attributed-to-cranial-or-cervical-vascular-disorder\/6-8-headache-attributed-to-genetic-vasculopathy\/"},{"issue":"1","key":"1536_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/08990220.2020.1720636","volume":"37","author":"H Chen","year":"2020","unstructured":"Chen H, Hu Q, Raza HK, Chansysouphanthong T, Singh S, Rai P, et al. An analysis of the clinical and imaging features of mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Somatosens Mot Res. 2020;37(1):45\u20139.","journal-title":"Somatosens Mot Res"},{"key":"1536_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/head.13219","volume":"58","author":"T Kraya","year":"2017","unstructured":"Kraya T, Deschauer M, Joshi PR, Zierz S, Gaul C. Prevalence of headache in patients with mitochondrial disease: A cross-sectional study. Headache: J Head Face Pain. 2017;58:45\u201352.","journal-title":"Headache: J Head Face Pain"},{"key":"1536_CR14","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.3390\/ijms26115241","volume":"26","author":"G Han","year":"2025","unstructured":"Han G, Yao M, Ni J. Recent advances in genetics of moyamoya disease: Insights into the different pathogenic pathways. Int J Mol Sci. 2025;26:5241.","journal-title":"Int J Mol Sci"},{"key":"1536_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70316","author":"N Rifino","year":"2025","unstructured":"Rifino N, Aamodt AH, Wiedmann M, Kramer M, Becker J, Guey S, et al. The spectrum of headaches in moyamoya angiopathy: from mechanisms to management strategies\u2014a consensus review from the NEUROVASC Working Group. Eur J Neurol. 2025 Oct;32(10):e70316. https:\/\/doi.org\/10.1111\/ene.70316","journal-title":"Eur J Neurol"},{"key":"1536_CR16","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1093\/brain\/awad193","volume":"146","author":"G Banerjee","year":"2023","unstructured":"Banerjee G, Collinge J, Fox NC, Lashley T, Mead S, Schott JM, et al. Clinical considerations in early-onset cerebral amyloid angiopathy. Brain. 2023;146:3991\u20134014.","journal-title":"Brain"},{"key":"1536_CR17","doi-asserted-by":"publisher","first-page":"120866","DOI":"10.1016\/j.jns.2023.120866","volume":"454","author":"M Cozza","year":"2023","unstructured":"Cozza M, Amadori L, Boccardi V. Exploring cerebral amyloid angiopathy: Insights into pathogenesis, diagnosis, and treatment. J Neurol Sci. 2023;454:120866.","journal-title":"J Neurol Sci"},{"key":"1536_CR18","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","volume":"21","author":"A Charidimou","year":"2022","unstructured":"Charidimou A, Boulouis G, Frosch MP, Baron J-C, Pasi M, Albucher JF, et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: A multicentre, retrospective, MRI\u2013Neuropathology Diagnostic Accuracy Study. Lancet Neurol. 2022;21:714\u201325.","journal-title":"Lancet Neurol"},{"key":"1536_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1212\/WNL.0000000000012234","volume":"97","author":"EE Smith","year":"2021","unstructured":"Smith EE, Charidimou A, Ayata C, Werring DJ, Greenberg SM. Cerebral amyloid angiopathy\u2013related transient focal neurologic episodes. Neurology. 2021;97:231\u20138.","journal-title":"Neurology"},{"key":"1536_CR20","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/bpa.12178","volume":"24","author":"GR Kolar","year":"2014","unstructured":"Kolar GR, Kothari PH, Khanlou N, Jen JC, Schmidt RE, Vinters HV. Neuropathology and genetics of cerebroretinal vasculopathies. Brain Pathol. 2014;24:510\u20138.","journal-title":"Brain Pathol"},{"key":"1536_CR21","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/brain\/aww217","volume":"139","author":"AH Stam","year":"2016","unstructured":"Stam AH, Kothari PH, Shaikh A, Gschwendter A, Jen JC, Hodgkinson S, et al. Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations. Brain. 2016;139:2909\u201322.","journal-title":"Brain"},{"key":"1536_CR22","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000214703","author":"AL Ford","year":"2026","unstructured":"Ford AL, Kang P, Fellah S, Astafiev SV, Ratliff A, Fiala M, et al. Neuroimaging biomarkers of disease progression and cognitive change in patients with retinal vasculopathy with cerebral leukoencephalopathy. Neurology. 2026;106(6):e214703. https:\/\/doi.org\/10.1212\/wnl.0000000000214703","journal-title":"Neurology"},{"key":"1536_CR23","doi-asserted-by":"publisher","first-page":"e2078","DOI":"10.1212\/WNL.0000000000006567","volume":"91","author":"S Zagaglia","year":"2018","unstructured":"Zagaglia S, Selch C, Nisevic JR, Mei D, Michalak Z, Hernandez-Hernandez L, et al. Neurologic phenotypes associated with COL4A1\/2 mutations. Neurology. 2018;91:e2078\u201388.","journal-title":"Neurology"},{"key":"1536_CR24","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/head.12169","volume":"53","author":"SD Silberstein","year":"2013","unstructured":"Silberstein SD, Dodick DW. Migraine genetics: Part II. Headache: J Head Face Pain. 2013;53:1218\u201329.","journal-title":"Headache: J Head Face Pain"},{"key":"1536_CR25","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/head.13053","volume":"57","author":"HG Sutherland","year":"2017","unstructured":"Sutherland HG, Griffiths LR. Genetics of migraine: Insights into the molecular basis of migraine disorders. Headache: J Head Face Pain. 2017;57:537\u201369.","journal-title":"Headache: J Head Face Pain"},{"key":"1536_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1355281","author":"K Frimpong-Manson","year":"2024","unstructured":"Frimpong-Manson K, Ortiz YT, McMahon LR, Wilkerson JL. Advances in understanding migraine pathophysiology: a bench to bedside review of research insights and therapeutics. Front Mol Neurosci. 2024;17:1355281. https:\/\/doi.org\/10.3389\/fnmol.2024.1355281","journal-title":"Front Mol Neurosci"},{"key":"1536_CR27","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.2147\/JPR.S329280","volume":"15","author":"K Suzuki","year":"2022","unstructured":"Suzuki K, Suzuki S, Shiina T, Kobayashi S, Hirata K. Central sensitization in migraine: A narrative review. J Pain Res. 2022;15:2673\u201382.","journal-title":"J Pain Res"},{"key":"1536_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10072-012-1041-x","volume":"33","author":"E Agostoni","year":"2012","unstructured":"Agostoni E, Rigamonti A. Migraine and small vessel diseases. Neurol Sci. 2012;33:51\u20134.","journal-title":"Neurol Sci"},{"key":"1536_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.mito.2020.05.004","volume":"53","author":"LH Tiehuis","year":"2020","unstructured":"Tiehuis LH, Koene S, Saris CGJ, Janssen MCH. Mitochondrial migraine; a prevalence, impact and treatment efficacy cohort study. Mitochondrion. 2020;53:128\u201332.","journal-title":"Mitochondrion"},{"key":"1536_CR30","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1161\/STROKEAHA.112.665927","volume":"43","author":"F Pescini","year":"2012","unstructured":"Pescini F, Nannucci S, Bertaccini B, Salvadori E, Bianchi S, Ragno M, et al. The cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) scale. Stroke. 2012;43:2871\u20136.","journal-title":"Stroke"},{"key":"1536_CR31","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/head.14153","volume":"61","author":"J Ailani","year":"2021","unstructured":"Ailani J, Burch RC, Robbins MS. The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache: J Head Face Pain. 2021;61:1021\u201339.","journal-title":"Headache: J Head Face Pain"},{"key":"1536_CR32","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ana.25831","volume":"88","author":"IA Mulder","year":"2020","unstructured":"Mulder IA, Li M, de Vries T, Qin T, Yanagisawa T, Sugimoto K, et al. Anti-migraine calcitonin gene\u2013related peptide receptor antagonists worsen cerebral ischemic outcome in mice. Ann Neurol. 2020;88:771\u201384.","journal-title":"Ann Neurol"},{"key":"1536_CR33","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/head.14942","volume":"65","author":"AM Kuczynski","year":"2025","unstructured":"Kuczynski AM, Kingston WS. Genetic migraine disorders and the response to calcitonin gene-related peptide antagonist treatment. Headache: J Head Face Pain. 2025;65:1041\u20133.","journal-title":"Headache: J Head Face Pain"},{"key":"1536_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/head.14692","volume":"64","author":"AC Charles","year":"2024","unstructured":"Charles AC, Digre KB, Goadsby PJ, Robbins MS, Hershey A. Calcitonin gene-related peptide\u2010targeting therapies are a first\u2010line option for the prevention of migraine: an American Headache Society Position Statement Update. Headache. 2024;64:333\u201341.","journal-title":"Headache"},{"key":"1536_CR35","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s40264-019-00837-y","volume":"42","author":"W Sch\u00e4fer","year":"2019","unstructured":"Sch\u00e4fer W, Princk C, Kollhorst B, Schink T. Antidepressants and the risk of hemorrhagic stroke in the elderly: a nested case\u2013control study. Drug Saf. 2019;42:1081\u20139.","journal-title":"Drug Saf"},{"key":"1536_CR36","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.ecl.2019.08.013","volume":"48","author":"MC Foy","year":"2019","unstructured":"Foy MC, Vaishnav J, Sperati CJ. Drug-induced hypertension. Endocrinol Metab Clin North Am. 2019;48:859\u201373.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"1536_CR37","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1161\/CIR.0000000000000426","volume":"134","author":"RL Page","year":"2016","unstructured":"Page RL, O\u2019Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, et al. Drugs that may cause or exacerbate heart failure. Circulation. 2016;134(6):e32\u201369.","journal-title":"Circulation"},{"key":"1536_CR38","doi-asserted-by":"publisher","DOI":"10.1177\/03331024251388377","author":"H Yuan","year":"2025","unstructured":"Yuan H, Orr SL, Al-Karagholi MAM, Ashina M, Cohen F, Diener H-C, et al. International Headache Society evidence-based guidelines on the use of non-invasive neuromodulation devices for the acute and preventive treatment of migraine. Cephalalgia. 2025;45(10):29. https:\/\/doi.org\/10.1177\/03331024251388377","journal-title":"Cephalalgia"},{"issue":"23","key":"1536_CR39","doi-asserted-by":"publisher","first-page":"e2318","DOI":"10.1212\/WNL.0000000000200299","volume":"98","author":"RJ Stefanetti","year":"2022","unstructured":"Stefanetti RJ, Ng YS, Errington L, Blain AP, McFarland R, Gorman GS. L-arginine in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes. Neurology. 2022;98(23):e2318\u20132328.","journal-title":"Neurology"},{"key":"1536_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10194-012-0426-9","volume":"13","author":"I Donnini","year":"2012","unstructured":"Donnini I, Nannucci S, Valenti R, Pescini F, Bianchi S, Inzitari D, et al. Acetazolamide for the prophylaxis of migraine in Cadasil: A preliminary experience. J Headache Pain. 2012;13:299\u2013302.","journal-title":"J Headache Pain"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-026-01536-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-026-01536-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-026-01536-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:02:08Z","timestamp":1788015728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-026-01536-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1536"],"URL":"https:\/\/doi.org\/10.1007\/s11916-026-01536-x","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"16 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":1,"name":"Ethics","label":"Human and Animal Rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Bruce performs outcome adjudication for TETMedical Inc unrelated to the current work.","order":2,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"111"}}